Assessment of Patients with Hepatitis D
Özet
Objective: Hepatitis delta virus (HDV) is the smallest known virus to infect humans. HDV, a defective ribonucleic acid (RNA) virus, is also the most important cause of liver-related mortality in patients with hepatitis B. Fifteen-20 million people worldwide are estimated to be infected with HDV. In this study, we aimed to determine the epidemiological and clinical manifestations of HDV infection and to asses the data on clinical and laboratory findings, treatments, serologies and biopsy results in patients with HDV infection.
Anahtar kelimeler
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
-
SKA 16: Barış, Adalet ve Güçlü Kurumlar
Atıf için künye
PARLAK, E., ERTÜRK, A., PARLAK, M., Koşan, Z., Albayrak, A., Özkurt, Z., Özden, K., & EROL, S. (2015). Assessment of Patients with Hepatitis D. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 21(3), 80–84. https://doi.org/10.4274/vhd.40469
BibTeX
@article{parlak2015-225069,
author = {PARLAK, Emine and ERTÜRK, Ayse and PARLAK, Mehmet and Koşan, Zahide and Albayrak, Ayşe and Özkurt, Zülal and Özden, Kemalettin and EROL, Serpil},
title = {Assessment of Patients with Hepatitis D},
journal = {VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL},
year = {2015},
volume = {21},
number = {3},
pages = {80--84},
issn = {1307-9441},
doi = {10.4274/vhd.40469},
url = {https://akademik.atauni.edu.tr/yayinlar/225069-assessment-of-patients-with-hepatitis-d}
}